Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Market Observational Study of ESId (MDW Hematology Parameter) for Early Sepsis Detection in the Emergency Department (US Hospitals) and Potential Reduction in Time to Antibiotics - Baylor Scott & White Medical Center

NCT04291417 is registered in ClinicalTrials.gov with Beckman Coulter, Inc. as lead sponsor.

NCT NCT04291417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04291417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Market Observational Study of ESId (MDW Hematology Parameter) for Early Sepsis Detection in the Emergency Department (US Hospitals) and Potential Reduction in Time to Antibiotics - Baylor Scott & White Medical Center
Lead sponsor
Beckman Coulter, Inc.
Phase
Observational
Overall status
Completed
Start date
November 20, 2019
Completion date
June 17, 2020
Enrollment
1,700 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult disease, emergency department, sepsis, severe sepsis